Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

High-grade Glioma - A decade of care in Christchurch.

Yan SS, James ML, Kerstens P, de Lambert M, Robinson BA, Yi M.

J Med Imaging Radiat Oncol. 2019 Oct;63(5):665-673. doi: 10.1111/1754-9485.12944. Epub 2019 Aug 28.

PMID:
31464076
2.

Radiotherapy for metastatic spinal cord compression; can the Rades score predict survival?

Kerstens P, Yi M, James M.

Asia Pac J Clin Oncol. 2019 Dec;15(6):331-336. doi: 10.1111/ajco.13232. Epub 2019 Aug 22.

PMID:
31436904
3.

Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis.

Akdemir G, Markusse IM, Bergstra SA, Goekoop RJ, Molenaar ET, van Groenendael JHLM, Kerstens PJSM, Lems WF, Huizinga TWJ, Allaart CF.

RMD Open. 2018 May 20;4(1):e000649. doi: 10.1136/rmdopen-2018-000649. eCollection 2018.

4.

TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.

Loef M, Kroon FPB, Bergstra SA, van der Pol JA, Lems WF, Kerstens PJSM, Allaart CF, Kloppenburg M.

Rheumatology (Oxford). 2018 Nov 1;57(11):1917-1924. doi: 10.1093/rheumatology/key016.

PMID:
29471377
5.

Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial.

Ter Wee MM, Coupé VM, den Uyl D, Blomjous BS, Kooijmans E, Kerstens PJ, Nurmohamed MT, van Schaardenburg D, Voskuyl AE, Boers M, Lems WF.

RMD Open. 2017 Oct 25;3(2):e000502. doi: 10.1136/rmdopen-2017-000502. eCollection 2017.

6.

Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.

Konijn NPC, van Tuyl LHD, Boers M, den Uyl D, Ter Wee MM, van der Wijden LKM, Bultink IEM, Kerstens PJSM, Voskuyl AE, van Schaardenburg D, Nurmohamed MT, Lems WF.

Rheumatology (Oxford). 2017 Sep 1;56(9):1586-1596. doi: 10.1093/rheumatology/kex223.

PMID:
28859326
7.

Age affects joint space narrowing in patients with early active rheumatoid arthritis.

Matthijssen XM, Akdemir G, Markusse IM, Stijnen T, Riyazi N, Han KH, Bijkerk C, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

RMD Open. 2016 Oct 18;2(2):e000338. eCollection 2016.

8.

Do Short and Sustained Periods of American College of Rheumatology/European League Against Rheumatism Remission Predict Functional and Radiographic Outcome in Early Rheumatoid Arthritis Patients With Low Overall Damage Progression?

Konijn NPC, van Tuyl LHD, Boers M, den Uyl D, Ter Wee MM, Kerstens P, Voskuyl AE, van Schaardenburg D, Nurmohamed MT, Lems WF.

Arthritis Care Res (Hoboken). 2017 Jul;69(7):989-996. doi: 10.1002/acr.23112. Epub 2017 Jun 7.

9.

Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission.

Akdemir G, Markusse IM, Goekoop-Ruiterman YP, Steup-Beekman GM, Grillet BA, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Clin Rheumatol. 2017 Feb;36(2):317-326. doi: 10.1007/s10067-016-3405-8. Epub 2016 Sep 28.

10.

The short-term effects of two high-dose, step-down prednisolone regimens on body composition in early rheumatoid arthritis.

Konijn NP, van Tuyl LH, Boers M, van de Ven PM, den Uyl D, Ter Wee MM, Kerstens P, Voskuyl AE, van Schaardenburg D, Lems WF, Nurmohamed MT.

Rheumatology (Oxford). 2016 Sep;55(9):1615-22. doi: 10.1093/rheumatology/kew221. Epub 2016 May 31.

PMID:
27247434
11.

Effectiveness of four dynamic treatment strategies in patients with anticitrullinated protein antibody-negative rheumatoid arthritis: a randomised trial.

Akdemir G, Markusse IM, Dirven L, Riyazi N, Steup-Beekman GM, Kerstens P, Lems WF, Huizinga T, Allaart CF.

RMD Open. 2016 Mar 25;2(1):e000143. doi: 10.1136/rmdopen-2015-000143. eCollection 2016.

12.

Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment: A Randomized Trial.

Markusse IM, Akdemir G, Dirven L, Goekoop-Ruiterman YP, van Groenendael JH, Han KH, Molenaar TH, Le Cessie S, Lems WF, van der Lubbe PA, Kerstens PJ, Peeters AJ, Ronday HK, de Sonnaville PB, Speyer I, Stijnen T, Ten Wolde S, Huizinga TW, Allaart CF.

Ann Intern Med. 2016 Apr 19;164(8):523-31. doi: 10.7326/M15-0919. Epub 2016 Mar 1.

PMID:
27089068
13.

Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis.

Bergstra SA, Markusse IM, Akdemir G, Ronday HK, Han KH, Lems WF, Kerstens PJSM, van den Berg R, Landewé RBM, Allaart CF.

Clin Rheumatol. 2016 Aug;35(8):2101-2107. doi: 10.1007/s10067-015-3145-1. Epub 2015 Dec 22.

14.

Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study.

Markusse IM, Dirven L, Gerards AH, van Groenendael JH, Ronday HK, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Res Ther. 2015 Aug 31;17:232. doi: 10.1186/s13075-015-0730-2.

15.

Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation.

Markusse IM, Dirven L, Han KH, Ronday HK, de Sonnaville PB, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Care Res (Hoboken). 2016 Apr;68(4):446-53. doi: 10.1002/acr.22681.

16.

Effective Treatment for Rapid Improvement of Both Disease Activity and Self-Reported Physical Activity in Early Rheumatoid Arthritis.

Konijn NP, van Tuyl LH, Boers M, den Uyl D, Ter Wee MM, Kerstens P, Voskuyl AE, Nurmohamed M, van Schaardenburg D, Lems WF.

Arthritis Care Res (Hoboken). 2016 Feb;68(2):280-4. doi: 10.1002/acr.22668.

17.

Continued participation in a ten-year tight control treat-to-target study in rheumatoid arthritis: why keep patients doing their best?

Markusse IM, Dirven L, Han KH, Ronday HK, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Care Res (Hoboken). 2015 May;67(6):739-45. doi: 10.1002/acr.22540.

18.

Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis.

Markusse IM, de Vries-Bouwstra JK, Han KH, van der Lubbe PA, Schouffoer AA, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Res Ther. 2014 Sep 25;16(5):430. doi: 10.1186/s13075-014-0430-3.

19.

A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study.

Markusse IM, Dirven L, van den Broek M, Bijkerk C, Han KH, Ronday HK, Bolce R, Sasso EH, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

J Rheumatol. 2014 Nov;41(11):2114-9. doi: 10.3899/jrheum.131412. Epub 2014 Aug 15.

20.

Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.

ter Wee MM, den Uyl D, Boers M, Kerstens P, Nurmohamed M, van Schaardenburg D, Voskuyl AE, Lems WF.

Ann Rheum Dis. 2015 Jun;74(6):1233-40. doi: 10.1136/annrheumdis-2013-205143. Epub 2014 May 12.

PMID:
24818633
21.

Best practice rosters--are mandatory split nights rosters really the answer?

Welsh F, Campbell S, Chang WK, Kerstens P, Smith N.

N Z Med J. 2013 Dec 13;126(1387):192-3. No abstract available.

PMID:
24362748
22.

A simple method of postgastric bypass laparoscopic-assisted endoscopic retrograde cholangiopancreatography.

Kerstens P, Stace N, Wickremesekera SK, Bann S.

Ann R Coll Surg Engl. 2013 Sep;95(6):446. doi: 10.1308/003588413X13629960048875l. No abstract available.

23.

A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeks.

den Uyl D, ter Wee M, Boers M, Kerstens P, Voskuyl A, Nurmohamed M, Raterman H, van Schaardenburg D, van Dillen N, Dijkmans B, Lems W.

Ann Rheum Dis. 2014 Jun;73(6):1071-8. doi: 10.1136/annrheumdis-2012-202818. Epub 2013 Apr 19.

24.

Early local swelling and tenderness are associated with large-joint damage after 8 years of treatment to target in patients with recent-onset rheumatoid arthritis.

van den Broek M, Dirven L, Kroon HM, Kloppenburg M, Ronday HK, Peeters AJ, Kerstens PJ, Huizinga TW, Lems WF, Allaart CF.

J Rheumatol. 2013 May;40(5):624-9. doi: 10.3899/jrheum.121248. Epub 2013 Apr 1.

PMID:
23547212
25.

Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients.

Heimans L, van den Broek M, le Cessie S, Siegerink B, Riyazi N, Han KH, Kerstens PJ, Huizinga TW, Lems WF, Allaart CF.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1235-42. doi: 10.1002/acr.21978.

26.

Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy.

Dirven L, Klarenbeek NB, van den Broek M, van Groenendael JH, de Sonnaville PB, Kerstens PJ, Huizinga TW, Dijkmans BA, Lems WF, Allaart CF.

Clin Rheumatol. 2013 May;32(5):585-90. doi: 10.1007/s10067-012-2136-8. Epub 2012 Dec 9.

PMID:
23224330
27.

Large-joint damage in patients with early rheumatoid arthritis and its association with treatment strategy and damage of the small joints.

Dirven L, van den Broek M, Kroon HM, Grillet BA, Han KH, Kerstens PJ, Huizinga TW, Lems WF, Allaart CF.

Rheumatology (Oxford). 2012 Dec;51(12):2262-8. doi: 10.1093/rheumatology/kes228. Epub 2012 Sep 1.

PMID:
22942403
28.

Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis.

Dirven L, van den Broek M, van Groenendael JH, de Beus WM, Kerstens PJ, Huizinga TW, Allaart CF, Lems WF.

BMC Musculoskelet Disord. 2012 Jul 23;13:125. doi: 10.1186/1471-2474-13-125.

29.

'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA'.

Koevoets R, Dirven L, Klarenbeek NB, van Krugten MV, Ronday HK, van der Heijde DM, Huizinga TW, Kerstens PS, Lems WF, Allaart CF.

Ann Rheum Dis. 2013 Jun;72(6):870-4. doi: 10.1136/annrheumdis-2011-201191. Epub 2012 Jun 30.

PMID:
22753403
30.

Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up.

van den Broek M, Dirven L, de Vries-Bouwstra JK, Dehpoor AJ, Goekoop-Ruiterman YP, Gerards AH, Kerstens PJ, Huizinga TW, Lems W, Allaart CF.

Ann Rheum Dis. 2012 Sep;71(9):1530-3. doi: 10.1136/annrheumdis-2011-201212. Epub 2012 Apr 24.

PMID:
22532630
31.

Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies.

van der Woude D, Visser K, Klarenbeek NB, Ronday HK, Peeters AJ, Kerstens PJ, Dijkmans BA, Huizinga TW, van der Helm-van Mil AH, Allaart CF.

Rheumatology (Oxford). 2012 Jun;51(6):1120-8. doi: 10.1093/rheumatology/ker516. Epub 2012 Feb 15.

PMID:
22337939
32.

The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study.

van den Broek M, Dirven L, Klarenbeek NB, Molenaar TH, Han KH, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2012 Feb;71(2):245-8. doi: 10.1136/annrheumdis-2011-200379. Epub 2011 Nov 21.

PMID:
22110122
33.

Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression.

Dirven L, Visser K, Klarenbeek NB, Ewals JA, Han KH, Peeters AJ, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Scand J Rheumatol. 2012 Feb;41(1):15-9. doi: 10.3109/03009742.2011.594964. Epub 2011 Nov 21.

PMID:
22103436
34.

Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.

Klarenbeek NB, Koevoets R, van der Heijde DM, Gerards AH, Ten Wolde S, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Oct;70(10):1815-21. doi: 10.1136/ard.2010.149260. Epub 2011 Aug 3.

PMID:
21813548
35.

Simplified versions of the original disease activity score: validation in the BeSt trial.

Koevoets R, Klarenbeek NB, Güler-Yüksel M, van Oosterhout M, van Krugten MV, Kerstens PJ, Huizinga TW, Dijkmans BA, van der Heijde DM, Allaart CF.

Ann Rheum Dis. 2011 Aug;70(8):1471-4. doi: 10.1136/ard.2010.149146. Epub 2011 May 8.

PMID:
21551508
36.

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study.

van den Broek M, Klarenbeek NB, Dirven L, van Schaardenburg D, Hulsmans HM, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Aug;70(8):1389-94. doi: 10.1136/ard.2010.147751. Epub 2011 Apr 24.

PMID:
21515916
37.

The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study.

Klarenbeek NB, Güler-Yüksel M, van der Kooij SM, Han KH, Ronday HK, Kerstens PJ, Seys PE, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Jun;70(6):1039-46. doi: 10.1136/ard.2010.141234. Epub 2011 Mar 17.

PMID:
21415052
38.

Recent advances in the management of rheumatoid arthritis.

Klarenbeek NB, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

BMJ. 2010 Dec 21;341:c6942. doi: 10.1136/bmj.c6942. Review. No abstract available.

PMID:
21177351
39.

A comparison between the simplified erosion and narrowing score and the Sharp-van der Heijde score: post hoc analysis from the Best study.

Klarenbeek NB, Güler-Yüksel M, van der Heijde DM, Kerstens PJ, Mallée C, Westedt ML, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Apr;70(4):714-6. doi: 10.1136/ard.2010.134346. Epub 2010 Dec 14. No abstract available.

PMID:
21156760
40.

A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study.

van der Kooi E, Klarenbeek NB, Güler-Yüksel M, Kerstens PJ, van der Lubbe PA, Westedt ML, ten Wolde S, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Jan;70(1):168-71. doi: 10.1136/ard.2010.133132. Epub 2010 Nov 29.

PMID:
21115551
41.

Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study.

Klarenbeek NB, van der Kooij SM, Güler-Yüksel M, van Groenendael JH, Han KH, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Feb;70(2):315-9. doi: 10.1136/ard.2010.136556. Epub 2010 Nov 10.

PMID:
21068104
42.

Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab.

Klarenbeek NB, Güler-Yüksel M, van der Heijde DM, Hulsmans HM, Kerstens PJ, Molenaar TH, de Sonnaville PB, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2010 Dec;69(12):2107-13. doi: 10.1136/ard.2010.131201. Epub 2010 Jul 7.

PMID:
20610442
43.

A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study.

Visser K, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ronday HK, Seys PE, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2010 Jul;69(7):1333-7. doi: 10.1136/ard.2009.121160. Epub 2010 May 24.

PMID:
20498212
44.

Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial.

Klarenbeek NB, van der Kooij SM, Huizinga TJ, Goekoop-Ruiterman YP, Hulsmans HM, van Krugten MV, Speyer I, de Vries-Bouwstra JK, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2010 Jul;69(7):1342-5. doi: 10.1136/ard.2009.124180. Epub 2010 May 14.

PMID:
20472597
45.

[The Dutch College of General Practitioners' practice guideline on arthritis].

Lems WF, Kerstens PJ.

Ned Tijdschr Geneeskd. 2009;153:A1368. Dutch.

PMID:
20051167
46.

IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.

van Tuyl LH, Lems WF, Kerstens PJ, Voskuyl AE, Dijkmans BA, Boers M.

Ann Rheum Dis. 2009 Oct;68(10):1652-3. doi: 10.1136/ard.2008.103184. No abstract available.

PMID:
19748920
47.

Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: a pilot implementation study.

van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Kerstens PJ, Dijkmans BA, Boers M.

J Rheumatol. 2009 Jul;36(7):1380-6. doi: 10.3899/jrheum.081078. Epub 2009 Jun 1.

PMID:
19487259
48.

The BeSt story: on strategy trials in rheumatoid arthritis.

Klarenbeek NB, Allaart CF, Kerstens PJ, Huizinga TW, Dijkmans BA.

Curr Opin Rheumatol. 2009 May;21(3):291-8. doi: 10.1097/BOR.0b013e32832a2f1c. Review.

PMID:
19318946
49.

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis.

van den Hout WB, Goekoop-Ruiterman YP, Allaart CF, de Vries-Bouwstra JK, Hazes JM, Kerstens PJ, van Zeben D, Hulsmans HM, de Jonge-Bok JM, de Sonnaville PB, Dijkmans BA, Breedveld FC.

Arthritis Rheum. 2009 Mar 15;61(3):291-9. doi: 10.1002/art.24169.

50.

DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Kerstens PJ, Nielen MM, Vos K, van Schaardenburg D, Speyer I, Seys PE, Breedveld FC, Allaart CF, Dijkmans BA.

Ann Rheum Dis. 2010 Jan;69(1):65-9. doi: 10.1136/ard.2008.097683.

PMID:
19155234

Supplemental Content

Loading ...
Support Center